Search
Searching with a thematic focus on Intellectual Property Rights, Trade Policy
Showing 21-30 of 420 results
Pages
- Document
The 3P proposal to accelerate innovation and access for new treatment regimens for TB
Access to Essential Medicines Campaign, MSF, 2014The aim of the ‘3P Project’ is to rapidly deliver affordable, effective new regimens for tuberculosis (TB) through an open collaborative approach to conducting drug development and through novel approaches to financing and coordinating R&D. The 3P Project implements three mechanisms to facilitate the necessary and appropriate R&D for TB regimens:DocumentThe economics of intellectual property rights in developing countries: lessons from a literature review
South African Institute of International Affairs, 2009Conventional economic theory asserts that inefficient markets result from a product or service for which there are no ready substitutes being provided by a single seller (i.e. a monopoly). An inefficient outcome is defined as one that does not maximise the welfare gains to society.DocumentEconomic partnership agreements and intellectual property rights protection: challenges for the Southern African Development Community region
South African Institute of International Affairs, 2009The signing of the comprehensive Economic Partnership Agreement (EPA) by the European Community (EC) and Caribbean Forum (CARIFORUM) countries covering a wide range of issues, including intellectual property (IP) provisions, has the potential to influence negotiations for other EPA groups that have only signed a series of ‘goods-only’ interim EPAs.Even though IP is not included as oDocumentTechnology diffusion through intellectual property rights: innovating to combat climate change
South African Institute of International Affairs, 2013Developing countries are the most affected by environmental degradation and yet lag behind industrialised nations in their access to, and adoption of, technologies.DocumentIntellectual property rights and South Africa's innovation future
South African Institute of International Affairs, 2008Intellectual property rights (IPR) and the legislation that manage them are not without problems andDocumentGreening Global Value Chains: Innovation and the International Diffusion of Technologies and Knowledge
World Bank, 2013Using novel data on patents, trade of equipment goods, and foreign direct investments and insights from the economic literature, this paper seeks to lay out the state of knowledge on the role of innovation and the diffusion of technologies in the greening of global value chains as well as some of the main policy issues.DocumentReconciling TRIPS and CBD through disclosure requirement
South Asia Watch on Trade, Economics & Environment, 2005The Convention on Biological Diversity (CBD) provides a multilaterally agreed set of rules for access to and sharing of benefits arising out of the commercial use of genetic resources, while WTO TRIPS agreement is sought to protect modern biotechnologies. In view of this, the current paper believes that CBD and TRIPS should be seen in conjunction with one another.DocumentProtecting farmers' rights in the global IPR regime: challenges and options for developing countries
South Asia Watch on Trade, Economics & Environment, 2007Farmers’ rights are about enabling farmers to continue as stewards and innovators of agro-biodiversity, and about rewarding them for their contribution to the global genetic pool. This policy brief outlines central challenges and options for the realisation of farmers’ rights, indicating that farmers’ rights are a vital means in the fight against poverty.DocumentThe conflict between Seed Bill and PPVFR Act of India
South Asia Watch on Trade, Economics & Environment, 2009The Indian seed policy and related laws and regulations are stand-alone domestic devices for setting and enforcing national seed standards. This policy brief is an analysis of the complementarities and contradictions between the legislation governing seed trade and seed-related IPRs in India.DocumentIntellectual property rights and public health: lessons from Thailand
South Asia Watch on Trade, Economics & Environment, 2009High prices of medicines is often the major cause of inaccessibility of medicines for poor patients in developing countries, and TRIPS agreement is often deemed as a main cause to raise medicines’ prices. However, there are avenues through the use of the TRIPS flexibilities – Thailand is an exemplary case study for other developing countries in this area.Pages
